6855
vs
ABBV
6855
ABBV
Over the past 12 months, Ascentage Pharma Group International has outperformed ABBV, delivering a return of +30% compared to the ABBV's +27% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
6855
ABBV